Joshua Ginzel

Conference Cancer Immunology Research · February 23, 2025 AbstractBreast cancer (BC) is the most frequently diagnosed cancer in women worldwide with more than 2 million new cases in 2020. The efficacy of immune checkpoint blockade (ICB) for BC is limited, with resp ... Full text Cite

Uncovering the role of oncogenic HER2 variants as drivers of pancreatic cancer.

Conference Journal of Clinical Oncology · February 2025 772Background: The therapeutic resistance of pancreatic ductal adenocarcinoma (PDAC) to conventional cytotoxic therapy unders ... Full text Cite

Abstract 2458: Targeting the CXCR3 axis in HER2+ breast cancer to enhance anti-tumor immunity

Conference Cancer Research · March 22, 2024 AbstractBreast cancer (BC) is the most frequently diagnosed cancer in women worldwide with more than 2 million new cases in 2020. The efficacy of immunotherapies for BC is limited, with response rates of &am ... Full text Cite